Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia

NCT01046526 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT01046526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01046526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Observational
Overall status
Completed
Start date
February 8, 2005
Completion date
May 3, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, psychopathology, schizophrenia